BATM subsidiary Adaltis has launched the ELISA Serological Test Kit for Covid-19, and has commenced the shipping of initial orders throughout Europe.
The CE-certified test is designed to find the IgA, IgM, and IgG antibodies for the SARS-CoV-2 virus that causes Covid-19. It can be conducted both on standard ELISA machines that are already in widespread use in laboratories and hospitals, and on Adaltis’s Personal LAB and NEXgen machines, which are pre-calibrated for these tests.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
BATM CEO Dr Zvi Marom said: “The serologic tests are now being provided to our customers at a time when they are most needed – to provide statistical information to decision makers. This, together with our other innovative initiatives, will help health authorities in preparing for a potential second wave of Covid-19 in the winter months.”
